Background Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor
blockers (ARBs) have been postulated to affect susceptibility to COVID-19. Observational …

Big data is important to new developments in global clinical science that aim to improve the
lives of patients. Technological advances have led to the regular use of structured electronic …

Highlights • Biopharma R&D productivity can be improved by implementing the FAIR Data
Principles. • FAIR enables powerful new AI analytics to access data for machine learning and …

Background Careful assessment of the reasons for discontinuation of active surveillance (AS)
is required for men with prostate cancer (PCa). Objective Using Movember's Global Action …

Objectives The Movember Foundation launched the Global Action Plan Prostate Cancer
Active Surveillance (GAP3) initiative to create a global consensus on the selection and …

Background Conservative management is an option for prostate cancer (PCa) patients either
with the objective of delaying or even avoiding curative therapy, or to wait until palliative …

Prostate Cancer Diagnosis and Treatment Enhancement Through the Power of Big Data in
Europe (PIONEER) is a European network of excellence for big data in prostate cancer, …

Dietary medium chain fatty acids (MCFA) and linoleic acid follow different metabolic routes,
and linoleic acid activates PPAR receptors. Both these mechanisms may modify lipoprotein …

Background The inclusion criterion for active surveillance (AS) is low- or intermediate-risk
prostate cancer. The predictive value of the presence of a suspicious lesion at magnetic …

Background Active surveillance (AS) enrolment criteria and follow-up schedules for low-risk
prostate cancer vary between institutions. However, uncertainty remains about adherence to …